News | SummitMD

In DES-PCI Era, Clopidogrel Gains Traction over Aspirin as Maintenance Monotherapy after DAPT

HOST-EXAM reports post-DAPT clopidogrel monotherapy drops ischemic and bleeding events by 30% in Korean population

June 21, 2021 8743 0 Read More

News | SummitMD

Asan Medical Center First in Asia to Complete 1,000 TAVI Cases

AMC Heart Team records 96% success rate with 1% mortality, complications rate for high-risk elderly patients

June 15, 2021 5731 0 Read More

News | SummitMD

ViV TAVR For Failing Surgical Valves Shows Promising Longer-Term Data

PARTNER II ViV results presented at TCT Connect 2020 raises expectations and questions in difficult patient group

November 12, 2020 8885 0 Read More

News | SummitMD

NIRS-IVUS Imaging Helps Detect Vulnerable Plaques, Patients at High Risk for Adverse Cardiac Events

PROSPECT II results presented at TCT Connect 2020 show combined intracoronary imaging helps identify lipid-rich non-flow limiting lesions associated with higher MACE risk

November 12, 2020 3439 1 Read More

News | SummitMD

Coronary CTA on Asymptomatic Patients Provides Little to No Clinical Benefit

Asan Medical Center research team finds increasing rate of coronary CTAs on domestic asymptomatic patients but little subsequent diagnostic, survival benefit

October 22, 2020 6534 0 Read More

News | SummitMD

Aspirin Alone Better for Post-TAVI Patients not on Anticoagulation: POPular TAVI

Study comparing aspirin+clopidogrel vs. aspirin shows aspirin alone reduced risk of all bleeding with no increased thrombotic risk for post-TAVI patients not on oral anticoagulation

October 15, 2020 3604 0 Read More

News | SummitMD

2nd SGLT-2 Inhibitor Scores in HF as Empagliflozin Reduces Hospitalization, CV Death in HFrEF

EMPEROR-Reduced: diabetes drug empagliflozin shows significant CV, renal benefits in HFrEF regardless of diabetes status

October 08, 2020 9199 0 Read More